远大医药:成都核药基地6月投入运营 全球首个“零辐射”智能核药工厂

中国网财经
19 May

中国网财经5月19日讯 继多款全球创新核药研发取得进展后,远大医药(0512.HK)昨日发布公告称,其位于成都温江的核药全球研发及生产基地已获得国家生态环境部颁发的甲级《辐射安全许可证》,并将于2025年6月正式投入运营。该基地于2022年底签约,2023年4月全面启动环评,同年11月获得施工许可正式破土动工。仅5个月实现主体封顶,以两年周期刷新了行业建设纪录,且是目前全球核素种类最全、自动化程度...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10